醫療食品市場規模、佔有率和成長分析：按管理途徑、按產品、按銷售管道、按應用、按地區 - 行業預測，2024-2031年

2022年，全球醫療食品市場規模為226億美元，預計從2023年的237.8億美元成長到2031年的356.7億美元，在預測期內（2024-2031年）複合年增長率為5.20%。

由於老年失智症、過動症、骨質疏鬆症、骨關節炎和各種中樞神經神經病變等慢性疾病盛行率的上升，醫療食品市場經歷顯著成長。此外，醫療專業人員還建議針對睡眠障礙、憂鬱症、纖維肌痛、創傷後壓力症候群（PTSD）以及有特定營養需求或消化器官系統問題的患者使用基於氨基酸的經腸營養，並強調這些產品是為患者量身定做的。藥物開發的進步和疾病特異性製劑的引進進一步促進了這種擴張。雀巢等行業領導者處於創建個人化臨床營養解決方案的前沿，用於糖尿病管理的 Metanx 和用於治療憂鬱症的 Deprin 等產品已經證明了這一點。醫療食品越來越被認為是在醫療監督下結合藥物和膳食食品元素的混合，可有效控制帕金森氏症和阿茲海默症疾病。醫療食品與傳統營養食品之間的區別在於醫療食品經過嚴格的臨床測試，這需要食品目的是解決的疾病狀態有透徹的了解。隨著醫療保健提供者評估患者的營養需求和健康狀況，醫療食品擴大受到推薦並獲得消費者的認可和接受。這些因素導致當今醫療保健領域對醫療食品的受歡迎程度和需求迅速上升。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二級資料和一級資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 依細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 抑制因素和挑戰
• 波特分析與影響
  • 競爭公司之間的敵對關係
  • 替代品的威脅
  • 買方議價能力
  • 新進入者的威脅
  • 供應商的議價能力

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 技術進步
• 監管環境
• 價值鏈分析
• 案例研究分析
• PESTEL分析
• 總體經濟指標
• 市場吸引力指數
• 價格分析

醫療食品市場：依管理途徑

• 市場概況
• 口服
• 腸內

醫療食品市場：依產品

• 市場概況
• 粉末
• 錠劑
• 液體
• 其他

醫療食品市場：依銷售管道分類

• 市場概況
• 網路銷售
• 零售
• 向機構投資者出售

醫療食品市場：依應用分類

• 市場概況
• 慢性腎臟病
• 輕度肝性腦病變
• 化療引起的腹瀉
• 病原體相關感染疾病
• 糖尿病神經病變
• ADHD
• 憂鬱症
• 阿茲海默症
• 營養不良
• 罕見疾病
  • 酪胺酸血症
  • 嗜伊紅性食道炎
  • FPIES
  • 苯酮尿症
  • MSUD
  • 高胱氨酸尿症
  • 其他
• 傷口癒合
• 其他

醫療食品市場：依地區

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 阿拉伯聯合大公國國家
  • 南非
  • 其他中東、非洲

競爭資訊

• 前5名企業比較
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 依細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Danone
• Nestle
• Abbott
• Targeted Medical Pharma Inc.（Physician Therapeutics LLC, a division of the company）
• Primus Pharmaceuticals Inc.
• Fresenius Kabi AG
• Kate Farms
• Ajinomoto Cambrooke
• Nutricia North America
• GlaxoSmithKline
• B. Braun Medical Inc.
• BioCare
• NutriScience Innovations
• Ajinomoto Health & Nutrition
• Baxter International
• Fresenius Kabi

結論和建議

Global Medical Foods Market size was valued at USD 22.60 billion in 2022 and is poised to grow from USD 23.78 billion in 2023 to USD 35.67 billion by 2031, growing at a CAGR of 5.20% during the forecast period (2024-2031).

The market for medical foods is experiencing significant growth, driven by the rising prevalence of chronic diseases such as Alzheimer's, ADHD, osteoporosis, osteoarthritis, and various central nervous system disorders. Additionally, medical professionals recommend amino acid-based enteral nutrition for conditions like sleep disorders, depression, fibromyalgia, and PTSD, highlighting the tailored nature of these products for patients with specific nutritional needs or digestive issues. This expansion is further fueled by advancements in drug development and the introduction of disease-specific formulations. Industry leaders, such as Nestle, have been at the forefront of creating personalized clinical nutrition solutions, evidenced by their products like Metanx for diabetes management and Deplin for addressing depression. Medical foods are increasingly recognized as hybrid entities that combine elements of pharmaceuticals and dietary supplements, administered under medical supervision to manage conditions such as Parkinson's and Alzheimer's disease effectively. The differentiation between medical foods and conventional nutritional supplements lies in the rigorous clinical testing that medical foods undergo, necessitating a thorough understanding of the conditions they are designed to address. As healthcare providers assess patients' nutritional needs and health conditions, medical foods are being increasingly recommended, enhancing their visibility and acceptance among consumers. These factors collectively contribute to the surging popularity and demand for medical foods in today's healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Foods market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Medical Foods Market Segmental Analysis

Global Medical Foods Market is segmented into Route of Administration, Product, Sales Channel, Application, and region. By animal type, the market is classified into Oral, and Enteral. Depending on the product, it is categorized into Powder, Pills, Liquid, and Other. According to end user, the market is divided into Online Sales, Retail Sales, and Institutional Sales. By Application, the market is segmented into Chronic Kidney Disease, Minimal Hepatic Encephalopathy, Chemotherapy Induced Diarrhoea, Pathogen Related Infections, Diabetic Neuropathy, ADHD, Depression, Alzheimer's Disease, Nutritional Deficiency, Orphan Diseases, Wound Healing, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Medical Foods Market

The global Medical Foods market is driven by the increasing incidence of chronic diseases such as diabetes, cardiovascular conditions, and metabolic disorders. As these health issues become more widespread, there is a growing need for dietary interventions tailored to individual health requirements. Medical foods play a crucial role in addressing these dietary needs, helping patients manage their symptoms effectively while promoting better health outcomes. By enhancing overall well-being and improving quality of life, the demand for these specialized nutritional products is set to rise significantly, underscoring the vital importance of medical foods in contemporary healthcare regimes.

Restraints in the Global Medical Foods Market

One of the key restraints in the Global Medical Foods market is the lack of education and awareness among medical professionals, patients, and caregivers regarding the significance and benefits of medical foods. Without effective communication and educational efforts, the acceptance and adoption of these products can be hindered. Many healthcare providers may not fully grasp the distinctions between medical foods, dietary supplements, and conventional foods, which can negatively impact prescription practices and ultimately affect patient outcomes. Therefore, enhancing knowledge and understanding in this area is crucial for improving the utilization of medical foods and ensuring they are appropriately integrated into patient care.

Market Trends of the Global Medical Foods Market

The Global Medical Foods market is experiencing significant growth driven by an increasing emphasis on chronic disease management, highlighting the pivotal role of medical foods in treating conditions such as diabetes, Alzheimer's disease, and gastrointestinal disorders. As healthcare systems prioritize preventative approaches and integrated care models, the demand for specialized nutritional products designed to target metabolic pathways and address specific dietary deficiencies is escalating. This trend underscores a transformative shift towards holistic treatment methodologies that combine medical and nutritional therapy, making medical foods a crucial component in the strategy to enhance patient outcomes and reduce healthcare costs globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Value Chain Analysis
• Case Study Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Market Attractiveness Index
• Pricing Analysis

Global Medical Foods Market Size by Route of Administration & CAGR (2024-2031)

• Market Overview
• Oral
• Enteral

Global Medical Foods Market Size by Product & CAGR (2024-2031)

• Market Overview
• Powder
• Pills
• Liquid
• Other

Global Medical Foods Market Size by Sales Channel & CAGR (2024-2031)

• Market Overview
• Online Sales
• Retail Sales
• Institutional Sales

Global Medical Foods Market Size by Application & CAGR (2024-2031)

• Market Overview
• Chronic Kidney Disease
• Minimal Hepatic Encephalopathy
• Chemotherapy Induced Diarrhoea
• Pathogen Related Infections
• Diabetic Neuropathy
• ADHD
• Depression
• Alzheimer's Disease
• Nutritional Deficiency
• Orphan Diseases
  • Tyrosinemia
  • Eosinophilic Esophagitis
  • FPIES
  • Phenylketonuria
  • MSUD
  • Homocystinuria
  • Others
• Wound Healing
• Others

Global Medical Foods Market Size & CAGR (2024-2031)

• North America, (Route of Administration, Product, Sales Channel, Application)
  • US
  • Canada
• Europe, (Route of Administration, Product, Sales Channel, Application)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Route of Administration, Product, Sales Channel, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Route of Administration, Product, Sales Channel, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Route of Administration, Product, Sales Channel, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Danone
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Targeted Medical Pharma Inc. (Physician Therapeutics LLC, a division of the company)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Primus Pharmaceuticals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kate Farms
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ajinomoto Cambrooke
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nutricia North America
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioCare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NutriScience Innovations
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ajinomoto Health & Nutrition
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation